![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Klox Technologies’ Fluorescent Light LumiHeal System Gets FDA’s De Novo Clearance
Klox Technologies’ Fluorescent Light LumiHeal System Gets FDA’s De Novo Clearance
Klox Technologies has received the FDA’s de novo clearance for its LumiHeal System, a fluorescent light energy-based therapeutic system.
The approved indication of the LumiHeal System is to provide fluorescent and blue light therapy for postsurgical incisions for scar management, the Laval, Quebec, Canada-based company said.
The LumiHeal System is a noninvasive, nonthermal treatment that uses fluorescent light energy to reduce the appearance and feel of acute postsurgical incisions.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct